<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-29T08:18:43Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/129054" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/129054</identifier><datestamp>2025-12-17T01:01:06Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles</dc:title>
   <dc:creator>Galluzzi, Lorenzo</dc:creator>
   <dc:creator>Levine, Beth</dc:creator>
   <dc:creator>Green, Douglas R.</dc:creator>
   <dc:creator>Kroemer, Guido</dc:creator>
   <dc:subject>615.01/.03</dc:subject>
   <dc:subject>Autophagy</dc:subject>
   <dc:subject>Pharmacological modulation</dc:subject>
   <dc:subject>Therapeutic potential</dc:subject>
   <dc:subject>Drug discovery</dc:subject>
   <dc:subject>Ciencias Biomédicas</dc:subject>
   <dc:subject>Farmacología (Medicina)</dc:subject>
   <dc:subject>32 Ciencias Médicas</dc:subject>
   <dc:subject>3209 Farmacología</dc:subject>
   <dc:description>Autophagy is central to the maintenance of organismal homeostasis in both physiological and pathological situations. Accordingly, alterations in autophagy have been linked to clinically relevant conditions as diverse as cancer, neurodegeneration and cardiac disorders. Throughout the past decade, autophagy has attracted considerable attention as a target for the development of novel therapeutics. However, such efforts have not yet generated clinically viable interventions. In this Review, we discuss the therapeutic potential of autophagy modulators, analyse the obstacles that have limited their development and propose strategies that may unlock the full therapeutic potential of autophagy modulation in the clinic.</dc:description>
   <dc:description>Depto. de Fisiología</dc:description>
   <dc:description>Fac. de Medicina</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2025-12-16T08:41:51Z</dc:date>
   <dc:date>2025-12-16T08:41:51Z</dc:date>
   <dc:date>2017-05</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/129054</dc:identifier>
   <dc:identifier>1474-1776</dc:identifier>
   <dc:identifier>10.1038/nrd.2017.22</dc:identifier>
   <dc:identifier>1474-1784</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat Rev Drug Discov. 2017 Jul;16(7):487–511.</dc:relation>
   <dc:rights>restricted access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Springer Nature</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>